Loading...
XJPX
2413
Market cap7.71bUSD
Jul 10, Last price  
1,870.00JPY
1D
-0.27%
1Q
16.95%
Jan 2017
26.99%
IPO
2,201.54%
Name

M3 Inc

Chart & Performance

D1W1MN
XJPX:2413 chart
P/E
25.42
P/S
3.55
EPS
73.57
Div Yield, %
1.12%
Shrs. gr., 5y
-0.06%
Rev. gr., 5y
15.74%
Revenues
351.36b
+23.33%
5,729,052,0007,475,339,0008,534,933,00011,811,960,00014,646,737,00019,040,810,00026,007,000,00036,887,234,00051,346,000,00064,660,000,00078,143,000,00094,471,000,000113,059,000,000130,973,000,000169,198,000,000208,159,000,000230,818,000,000238,883,000,000284,900,000,000351,363,000,000
Net income
49.10b
+21.28%
1,609,156,0001,965,554,0002,363,272,0002,956,067,0003,486,762,0004,492,941,0005,598,000,0008,415,000,0009,759,000,00012,508,000,00016,004,000,00019,684,000,00019,577,000,00021,635,000,00037,822,000,00063,845,000,00049,028,000,00045,271,000,00040,484,000,00049,100,000,000
CFO
70.26b
+35.79%
1,443,044,0002,351,669,0002,055,657,0003,535,129,0003,186,999,0005,326,855,0005,810,152,0008,896,000,0009,316,000,00012,136,000,00016,555,000,00015,913,000,00017,749,000,00026,789,000,00046,627,000,00052,108,000,00057,113,000,00058,310,000,00051,743,000,00070,262,000,000
Dividend
Mar 28, 202521 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

M3, Inc., a Japanese corporation established in 2000 and headquartered in Tokyo, primarily delivers internet-based services to physicians and other healthcare professionals. Its operations are strategically divided into five key segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. The company manages an extensive portfolio of digital platforms tailored for medical practitioners. This includes m3.com, an exclusive online portal offering healthcare information, and MR-kun, which enables member doctors to continuously access updates and content from the m3com system. QOL-kun further supports members with non-medical, life-enhancement information. For the general public, M3 operates AskDoctors, where registered medical experts address health and illness inquiries. On an international scale, the company provides MDLinx for U.S. medical professionals and Doctorsnetuk in the U.K., which assists pharmaceutical companies and hosts drug information databases across France, Germany, and Spain. Additionally, M3 supports career development for doctors and pharmacists through its m3com CAREER service. Beyond these online platforms, M3, Inc. engages in a wide array of activities within the medical and pharmaceutical sectors. This encompasses sales and marketing initiatives for pharmaceuticals and medical devices, along with the development, distribution, and maintenance of electronic medical records and equipment for healthcare institutions. The company also conducts surveys for medical professionals, offers online sales and marketing support to pharmaceutical firms, provides management consulting and assistance to medical facilities, operates home-visit nursing services, delivers human resources solutions for the healthcare industry, and manages clinical trial facilities. Originally incorporated as So-netM3, Inc., the company officially rebranded to M3, Inc. in January 2010.
IPO date
Sep 16, 2004
Employees
10,533
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT